US Patent Issued to Samsung Life Public Welfare Foundation on Oct. 7 for "Producing method of mesenchymal stem cell for prevention or treatment of brain neuronal disease including ghrelin treatment and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,935, issued on Oct. 7, was assigned to Samsung Life Public Welfare Foundation (Seoul, South Korea).

"Producing method of mesenchymal stem cell for prevention or treatment of brain neuronal disease including ghrelin treatment and use thereof" was invented by Jong Wook Chang (Seoul, South Korea) and Hyeong Seop Kim (Incheon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a producing method of a mesenchymal stem cell for brain neuronal disease prevention or treatment including ghrelin treatment, a composition for producing a mesenchymal stem cell for brain neuronal disease prevention or treatment, a mesenchymal stem cell produce...